Annual congress report
Published: 2021-05-14

Critical review of multidisciplinary approaches for managing sinonasal tumors with orbital involvement

Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy; Head and Neck Surgery & Forensic Dissection Research center (HNS&FDRc), Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy
Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy
Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy
Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy
Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy
Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy; Head and Neck Surgery & Forensic Dissection Research center (HNS&FDRc), Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy
Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy; Head and Neck Surgery & Forensic Dissection Research center (HNS&FDRc), Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy
anterior skull base endoscopic endonasal surgery induction chemotherapy orbital exenteration sinonasal tumors


Orbital invasion is frequently observed in tumors involving the maxillary, ethmoid and frontal sinuses given the proximity of the orbit to the sinonasal tract and ventral skull base. The main objective of the present review is to determine the existing evidences on the frequency, treatment, and outcomes of orbital invasion in benign and malignant sinonasal tumors. A systematic review of the literature published from 1995 to 2020 was performed and data sources included PubMed, Cochrane library, NCBI Bookshelf, National Guideline Clearinghouse. Orbital invasion was reported in 2-4% of inverted papillomas, 12-15% of fibro-osseous lesions, 27-32% of juvenile angiofibromas, 35-45% of low-grade malignancies, and 50-80% of high-grade cancers. Surgical resection with negative margins represents the cornerstone of management for benign and low-grade malignant tumors. Histology-specific induction chemotherapy can be used for high-grade sinonasal cancers in order to downstage the tumor and increase the possibility of orbital preservation. When a significant response to induction chemotherapy is observed, exclusive chemoradiation should be offered to improve overall survival rates. Appropriate reconstruction of any surgical defects is essential in order to minimize complications and optimize functional and aesthetic outcomes. Orbital apex invasion represents a negative prognostic factor. In conclusion, a multidisciplinary teamwork is mandatory to maximize local control, minimize morbidity and improve orbital preservation rates.


The proximity of the orbit to the sinonasal tract and ventral skull base facilitates tumoral infiltration of the orbital content via preformed pathways (e.g. inferior and superior orbital fissure, anterior and posterior ethmoidal foramina, nasolacrimal duct), neurovascular structures (e.g. infraorbital and supratrochlear nerves; ethmoidal arteries), or by direct extension through the bone (e.g. lamina papyracea, orbital floor and roof, nasal bones). The periorbit is a highly resistant barrier against invasion but, once the tumor has passed through it, no further barriers are able to prevent orbital content infiltration. Orbital involvement poses unique challenges in the management of sinonasal benign and malignant tumors since the eye represents a borderline anatomical region, between the intracranial and extracranial compartment, containing many neurovascular structures, with also relevant functional and aesthetic implications.

Traditionally, the standard treatment for sinonasal tumors in close proximity to the orbit was radical excision with orbital exenteration 1. Over the past 20 years, the increased attention to patient’s quality of life along with the development of endoscopic surgery and advances in multimodal treatment strategies have led to significant progresses in the management of sinonasal tumors with orbital invasion. As a result, in recent years, treatment protocols including orbital preservation have been increasingly adopted 2,3.

However, there are still several open issues. The definition of “orbital invasion” represents a source of confusion since a universally accepted stratification of the degrees of orbital invasion is lacking. Moreover, data emerging from the case-series available in literature are difficult to compare and sometimes conflicting in terms of surgical and non-surgical treatments adopted, indications for orbital preservation, needs for orbital reconstruction and recurrence rates.

In the present review, we analyze the multidisciplinary approaches currently available for managing benign and malignant sinonasal tumors invading the orbit, in an effort to critically appraise their survival, functional and aesthetic outcomes. The systematic review of the literature was conducted in accordance with current guidelines. Data sources including PubMed, Cochrane library, NCBI Bookshelf, National Guideline Clearinghouse were searched using keywords as follows: “sinonasal neoplasm”; “orbit”; “orbital involvement”; “sinonasal benign tumors”; “sinonasal malignant tumors”; “orbital management”. Our research was focused on the time period ranging from January 1995 to June 2020, in order to avoid discrepancy and to promote data consistency. Among the 137 selected articles, only the studies that met the following criteria were included: 1) English language articles; 2) adequate number of patients for significant statistical analysis; 3) appropriate survival analysis to compare data; 4) accurate description of orbital invasion and concerning survival data. Following these inclusion criteria, 21 articles were selected to be reviewed.


Symptoms can result from orbital compression, nasolacrimal duct obstruction, and real infiltration of the orbital content. Therefore, diplopia, epiphora, chemosis, visual changes, and proptosis may be observed in approximately 50% of the cases 4. However, the absence of these findings does not rule out the occurrence of tumoral invasion of the orbit. Computerized tomography (CT) of the paranasal sinuses is paramount for identification of orbital bone erosion or reabsorption, and enlargement of fissures and foramina. Moreover, bony lesions such as fibro-osseous tumors can be easily detected using the CT scan. Magnetic resonance imaging (MRI) is superior for analyzing orbital soft tissues, and distinguishing inflammatory secretions (e.g. in the lacrimal sac) from tumor. In addition, by comparing T1-weighted contrast enhanced and T2-weighted sequences, periorbital and extraocular muscles invasion can be distinguished from other changes such as peritumoral edema. The MRI protocol may be further refined by adding dynamic contrast-enhanced (DCE) and diffusion-weighted sequences (DWI) in order to better analyze the interface between orbit and tumor in difficult cases of recurrences after previous surgery and/or radiotherapy 5. In the suspect of a vascular tumor (e.g. juvenile angiofibroma), an angio-MRI and/or an angiography should be also performed in order to study the distribution of the arterial feeders to the tumor and, possibly, embolize them. With the exception of fibro-osseous lesions and of vascular tumors, where the diagnosis is exclusively based on radiology, all other cases of sinonasal tumors need an endoscopic endonasal evaluation with multiple biopsies to define the tumoral histology and plan the most appropriate range of multimodal treatment. In case of malignancy, neck ultrasound and total body contrast-enhanced CT scan or positron emission tomography (PET) scan are obtained to rule out regional or systemic spread, respectively.

Benign tumors

Benign tumors of the paranasal sinuses are a heterogeneous group of diseases, that reflects the wide spectrum of different tissues present in the sinonasal cavities from which they could originate. Rare pathologies per se, they might involve the orbit in a small percentage of cases, ranging from 2 to 15%; therefore, few data are available in literature (Tab. I). These tumors are generally slow growing lesions that compress without infiltrating the surrounding anatomical structures, invading the orbital compartment by means of bone reabsorption or via preformed skull fissures or foramina. In the majority of cases, the integrity of the periorbital layer is maintained, while the displacement of the orbital content can cause proptosis, diplopia due to extrinsic muscles abnormal mobility, decreased visual acuity until blindness secondary to optic nerve compression, ocular pain and epiphora 6.

The standard treatment of benign tumors is surgical resection, using endoscopic endonasal techniques, transfacial/transcranial resection, transorbital surgery or combined approaches, which could overcome the limits of a single surgical technique in the management of lesions affecting such a complex anatomical compartment. Orbital exenteration is rarely required for benign tumors and orbital preservation is generally obtained. Globally, when selecting the surgical approach, it is necessary to carefully balance the complete excision with the associated surgical morbidity, taking also into account that some selected residual benign tumors, usually tend to remain stable over time.

Fibro-osseous lesions (FOLs)

Benign sinonasal fibro-osseous tumors involving the orbit commonly arise from the frontal and ethmoidal bones, with osteomas representing the most frequent subtypes 6. While osteomas generally originate or involve the orbital bony walls, without invasion of the orbital contents, other FOLs such as fibrous dysplasia and ossifying fibroma may present higher rates of intraorbital invasion and related clinic 7. A common feature in this group of lesions is the slow rate of growth, which often makes patients asymptomatic for a long period of time; for this reason, the “wait and scan” policy could be a valid option while the choice of surgical resection should be based on the site of the tumor, its growth pattern as well as on the clinical presentation 8-10. The endoscopic endonasal technique has been proposed by many authors as a minimally invasive and effective surgical approach to treat these tumors, by using the drill cavitation technique. In this regard, the intraorbital component of the lesion can be used as a corridor to pass through without needing to expose all the external boundaries of the lesion (Fig. 1), which could be selectively separated from the orbital periosteum and carefully collapsed and removed 11,12. Nevertheless, additional external approaches may be required when the tumor extends anteriorly to the nasolacrimal duct or in cases of fronto-orbital tumors not easily manageable with an exclusive endoscopic treatment, as described by Georgalas et al. 8. In order to achieve complete resection, different approaches through different orbital structures (eyelid, eyebrow, conjunctiva) were successfully employed with minimal residual morbidity and aesthetic defects. In cases with massive involvement of the anterior and/or posterior wall of the frontal sinus, an osteoplastic flap or Riedel-Mosher approach is necessary to reach a complete and safe surgical excision. This is the reason why a teamwork including maxillofacial surgeons, neurosurgeons and ophthalmologists is generally required. Generally, no reconstruction of the orbital walls is performed, except in case of massive removal of the bony orbital floor (more than 50%) 8. A limited intranasal herniation of the orbital content may occur but the preservation of the periorbital layer prevents diplopia, enophthalmos, or facial deformity; however, in case of major removal of the periorbit or in extensive intraorbital dissection, the placement of a silastic sheet as a protection while pushing the orbital content into the orbital cavity may be sufficient to avoid postsurgical orbital complications and the need for secondary revision surgeries 13. In some cases of fibrous dysplasia, the lesion may involve the optic canal and orbital apex with optic nerve compression, resulting in progressive loss of visual acuity, color vision and peripheral and central field defects. Although elective surgery is not indicated for asymptomatic cases of optic nerve encasement, due to the potential risk of impaired optic nerve function, an immediate referral for surgical optic nerve decompression should be recommended if there is evidence of visual loss and periodic follow-up is essential to monitor any recurrences 10,14. It appears clear that such critical patients should be managed in a multidisciplinary way, by means of periodical radiological, ophthalmological and surgical evaluations to define the best treatment strategy.

Inverted papilloma (IP)

Sinonasal IP may invade the orbit in 2-4% of cases, involving frequently also the nasolacrimal system. However, especially in huge tumors spreading into the orbit, it’s difficult to define whether the IP has been originated from the lacrimal structures or from the paranasal sinuses, since the nasolacrimal duct also represents one of the most common route of diffusion of sinonasal tumors to the orbit 15,16. In the largest case-series of IPs invading the orbit currently available in literature, 10 cases were described and foci of malignant transformation were found in all cases, respectively six squamous cell carcinomas and four transitional cell carcinomas 15. The high rate of malignant transformation observed in IP involving the orbit was confirmed also by other authors reporting smaller case-series 17-19. Having in mind these critical issues, when dealing with a histologically-proven IP that shows an intraorbital extension at the preoperative MRI, one should keep in mind the possibility that this lesion might harbor foci of malignant transformation. Although in literature the mean recurrence rate is around 5-10% for sinonasal IPs 18, when the tumor invades the orbit the reported incidence of recurrence is considerably higher, ranging from 20 to 80% 18,19. This finding can be explained by the more frequent occurrence of malignant transformation compared to other IPs. In this regard, Johnson et al. 17 reported four cases of IP with orbital invasion, of whom three experienced recurrences after the initial surgery in a period ranging from 4 months to 6 years; similarly, Elner et al. 15 described a recurrence rate of 80% in a series of 10 cases. Considering such significant rates of recurrences, a multidisciplinary approach is recommended when dealing with sinonasal IPs invading the orbit. The radiologist should be consulted in order to exactly define the grade of orbital involvement and signs of clear infiltration; the pathologist plays a crucial role in analyzing the surgical specimen to find out possible signs of malignant transformation; medical and radiation oncologists should be also included in the design of treatment’s strategy whenever cancerization is detected. Few data are available in the current literature about the proper surgical management of these tumors but, taking into account their aggressive behavior, there is a general consensus that aggressive surgical resection is recommended in order to obtain complete removal of the lesion. Radical surgical treatment, even including orbital exenteration, may be required (Fig. 2) 15,18. No evidences are currently available regarding indications for adjuvant treatments in such cases; however, some authors suggested the importance of adjuvant radiotherapy in case of orbital involvement by an IP harboring signs of malignant transformation in order to improve long-term local control of disease 20,21.

Juvenile angiofibroma (JA)

This vascular tumor is supposed to originate from vascular embryonic remnants in the cancellous bone around the vidian canal and basisphenoid, typically showing an expansive and destructive pattern of growth with spread to adjacent anatomical compartments throughout foramina and fissures. Tumoral extension to the orbit, across the inferior orbital fissure, turns out to be a common finding in advanced staged lesions, ranging from 27 to 32% of cases 22. Ophthalmological disorders and visual defects are caused by direct compression of the eye, optic nerve and chiasm, with proptosis reported as the most frequent symptom 23. Considering that JA is a vascular lesion and its surgical removal carries a high risk of profuse bleeding, preoperative embolization is advised in advanced-stage cases, paying special attention to the feeding vessels coming from the internal carotid artery (ICA) which can be more frequently involved when the JA extends to the orbital compartment. Xu et al. 23, in a series of 18 patients affected by JA involving the orbit and optic nerve, described the occurrence of blood supply to the tumor from small arterial vessels branching from the ophthalmic artery, which should be properly recognized by the interventional radiologist and not embolized, in order to avoid vision loss due to central retinal artery occlusion 24. Different treatment strategies have been proposed in the last decades, such as radiotherapy, chemotherapy and hormone therapy, with little or no success. Surgical excision is considered as the best treatment option, aiming complete tumor excision to avoid persistent disease and therefore minimize recurrence rates. Nowadays, the increase of endoscopic surgical skills together with advances in surgical instrumentation, imaging and intraoperative surgical navigation systems allows a minimally invasive endoscopic endonasal resection even in advanced staged lesions, like those with orbital involvement. Compared to traditional transfacial approaches, the endoscopic endonasal surgery improves surgical results, with limited blood loss, reduced postoperative sequelae and minimized recurrence rates 25-28. In the surgical management of JA involving the orbit and orbital apex, particular care must be taken to avoid injury of the optic nerve, III, V2, and V1 cranial nerves. Similarly, adequate endoscopic surgical skills are required in order to manage intraoperative bleeding, especially for tumor feeders originating from the ophthalmic artery, which should be coagulated without damaging any intraorbital neurovascular structures.

Another crucial aspect is the management of a recurrent or persistent intraorbital JA, since tumoral regrowth in such areas has not been described frequently in literature and small remnants might undergo an involution over time. Therefore, in case of a partial resection with a stable asymptomatic intraorbital JA persistence (e.g. inferior orbital fissure), there is not a strict indication for an immediate revision surgery unless there is measurable tumor growth or new symptoms 26.

In the light of all these aspects, JAs should be treated in tertiary-care referral centers, specialized in skull base surgery, by a multidisciplinary team including ENT surgeon, neurosurgeons, ophthalmologist, neuroradiologists and interventional radiologists, in order to achieve best results in terms of complete resection and low morbidity for the patient.

Malignant tumors

Malignant sinonasal tumors are extremely rare, accounting about 3% of all head and neck tumors and less than 1% of all malignant neoplasms. They include a variety of different histotypes with different behaviors, survival outcomes and treatment protocols 29-31. The most frequentely encountered are squamous cell carcinoma, intestinal type adenocarcinoma (ITAC), esthesioneuroblatoma (ENB) and sinonasal undifferentiated carcinoma (SNUC) 32.

Sinonasal tumors are frequently diagnosed in advanced stages due to their delayed symptoms that easily mimick inflammatory diseases. The incidence of orbital invasion by sinonasal malignancies depends on the site of origin, histology, and aggressiveness of the specific tumor and it is reported between 62 and 82% of all ethmoidal tumors, 55% of maxillary neoplasms, and 46% of nasal cavity tumors 33. Tumors may invade the orbit through preformed pathways (nasolacrimal duct, orbital fissures, optic canal, ethmoidal foramina), neurovascular structures (infra- e supraorbital nerves) or by direct invasion transgressing surrounding bones (e.g. erosion of the lamina papyracea in most cases) 3,6. This condition inevitably impacts on survival rate, functional outcomes and therapeutic strategies. It has been widely accepted that the grade of orbital infiltration strongly impacts on prognosis, with worst survival rates in case of extensive orbital involvement 3,34. Different case series in literature reported 5-year disease free survival of 69% for tumors abutting the lamina papyracea, 51% for tumors invading the periorbital layer, 34% for tumors involving the orbital content and, lastly, down to nearly 0% in case of orbital apex involvement 3.

Grade of orbital invasion

Orbital invasion must be preoperatively graded, by means of an accurate radiological imaging, as minimal (erosion of lamina papyracea, loss of the fat plane between tumor and extraconal muscles, periorbital irregularities) or massive, often accompanied by clinical signs of orbital involvement (proptosis, visual loss, restriction of ocular motility) 35. The recent 8th edition of the AJCC (American Joint Committee on Cancer) cancer staging system considers orbit involvement as a significant factor upgrading tumor classification: tumor is staged as T3 when invasion is limited to orbital bony wall, as T4a in case of invasion of the anterior orbital contents, and as T4b when the orbital apex is involved. The lack of an officially recognized classification defining the depth of orbital involvement by the tumor poses some challenges. Firstly, comparison of results from different studies can be challenging 29. Secondly, the lack of a clear definition as to what constitutes orbital invasion has been a source of confusion, and an accurate distinction should be made between bony erosion, orbital soft tissues involvement and apex infiltration. Thirdly, considering that surgical resection has always been considered as the cornerstone in the management of sinonasal tumors invading the orbit, a recognized classification is needed in order to correctly define indications whether to preserve or exenterate the orbit. In fact, orbital exenteration appears to be an invasive procedure conditioning a significant functional defect, esthetic deformity and, consequently, emotional impact 29. Over the years, different classifications have been proposed, aimed to stratify patients according to tumor aggressiveness and to guide adequate treatment planning (Tab. II) 3,33,36,37. Current indications for orbital exenteration are: gross orbital contents invasion; extensive infiltration of the extraconal fat, extraocular muscles; intraconal and retrobulbar fat invasion; eye bulb and optic nerve involvement; bulbar conjunctiva or sclera, eyelid, and/or proximal lacrimal pathways infiltration. Although orbital apex involvement has been considered in the last decades as an indication to orbital exenteration 6,30,33, recent scientific reports found that, in such cases, prognosis remains poor regardless the extent of surgery and, in general, any kind of multimodal treatment adopted 3. Thus, current trends tend to exclude orbital exenteration when orbital apex is massively involved by the cancer.

Management of sinonasal tumors invading the orbit

The gold standard treatment of sinonasal malignancies invading the orbit still remains controversial, and it has been widely debated in recent literature. The main reasons are the small amount of available data and the lack of a standardized universally-accepted classification of orbital invasion, as previously mentioned 29. Traditionally, the standard treatment of sinonasal tumors invading the orbit was radical excision with orbital exenteration 1. In recent years, increased attention to patient’s quality of life, the refinement of minimally invasive endoscopic techniques and the development of multimodal treatment protocols have led to significant progress in managing such patients, with an ever-growing trend to orbital preservation. Currently, available treatments include surgical removal (via pure endoscopic surgery or open endoscopic-assisted surgery), chemotherapy in an induction or adjuvant setting, and adjuvant radiotherapy. All these therapeutic options must be previously discussed during a multidisciplinary tumor board 3,33.

Based on these assumptions, a histology-driven treatment algorithm has been proposed (Fig. 3) in order to offer tailored therapies to high-grade tumors (poorly differentiated squamous cell carcinoma, neuroendocrine carcinoma, esthesioneuroblastoma Hyams grade IV, sinonasal undifferentiated carcinoma, ITAC p53 wild type) and other specific treatments to well differentiated malignancies (adenocarcinoma, adenoid cystic carcinoma, low-grade esthesioneuroblastoma and squamous cell carcinoma) and to chemoresistant tumors (mucosal melanoma) 3. High-grade tumors might be submitted to induction chemotherapy 30, up to a maximum of five cycles, conducted with different protocols based on the specific histotype (TPF, PE/AI regimen, PFL regimen) 3; the response rate to induction chemotherapy is radiologically evaluated by seriated contrast-enhanced MRI and can be used to segregate “good responders” from “non-responders”. Patients achieving complete or good response (> 80% reduction of initial tumor volume) can be treated with exclusive orbital-sparing chemoradiation with curative intent (Fig. 4). Conversely, patients achieving partial response (tumor reduction inferior to 80%), non-responder patients (reduction inferior to 30%), and patients with disease progression might be directed to surgical resection, followed by adjuvant radiotherapy or chemoradiation (Fig. 5). On the other hand, patients affected by low-grade tumors, chemoresistant tumors, and high-grade tumors non-susceptible to systemic chemotherapy due to age and/or severe comorbidities, can be submitted to upfront surgery. When a surgical resection is planned, an endoscopic endonasal approach must be preferred when feasible, eventually combined with a traditional transfacial or craniofacial surgery in case of massive intracranial or facial skeleton involvement, always respecting the oncological principle of complete excision. The surgical management and the decision whether to preserve or exenterate the orbit, must be carefully discussed and planned according to the extent of orbital invasion. In case of limited orbital involvement (tumor abutting the orbital bones, erosion of lamina papyracea, orbital periosteum, minimal extraconal fat infiltration), an orbital-sparing endoscopic surgery might be adopted and intraoperative frozen sections examination should be used to assess the free-margins resection. Conversely, orbital exenteration should be planned in case of extensive invasion of the extraconal fat, extraocular muscles, intraconal and retrobulbar fat invasion, eye bulb and optic nerve involvement, bulbar conjunctiva or sclera infiltration, eyelid involvement, proximal lacrimal pathways invasion 3,30 (Fig. 6). When dealing with such advanced-stage sinonasal tumors, a postoperative radio(chemo)therapy is adopted almost invariably, according to the final histology report. Orbital apex infiltration by sinonasal cancer deserves separate consideration since it has been reported how orbital apex involvement is dramatically related to poor prognosis regardless the treatment strategy adopted and extent of surgery 3. A free-margins resection is virtually impossible in such cases due to the complex neurovascular anatomy of this site. Indeed, in such advanced cases, curative treatments are excluded and different forms of palliative surgery and/or chemoradiation should be adopted 3. Tumors with cavernous sinus invasion, internal carotid artery encasement or massive intracranial involvement should be considered unresectable as well 33,38.

Prognostic significance of orbital invasion

To date, it is widely accepted that orbital invasion by sinonasal tumors affects negatively the survival rates, as summarized by data emerging from the largest case-series currently available in literature (Tab. III). Several worldwide case series have supported the evidence that progressive involvement of the orbital structures decreases survival rates 38-40. Suarez et al. reported disease-specific survival rates of 41% in patients affected by sinonasal cancers with orbital invasion compared to 75% for those without orbital involvement 38. Although a clear consensus regarding the oncological safety of orbital preservation has not yet been reached, trends encouraging orbit-sparing surgery are renowned since many years. In this regard, Carrau et al. found that orbit preservation, when a full-thickness periorbit infiltration was excluded, did not downgrade oncological outcomes, while a full-thickness periorbit invasion was associated with a decreased prognosis. Their results suggested that eye preservation, in the absence of orbital soft tissues invasion, did not compromise the local control rate 4. In 2002, Imola and Schramm reported no differences in terms of survival rates between orbital preservation and orbital exenteration in patients with tumor invasion limited to the bony orbital walls 41. In 2006, Howard et al., as well, demonstrated that patients with preserved orbit didn’t have worst prognosis when the orbital periosteum was not breached yet by the tumor; thus, removal of the infiltrated periorbit with the conservation of the orbital content could be oncologically feasible 40. Therefore, sparing the soft tissues of the orbit when the periorbit have not been deeply transgressed by the tumor generally does not appear to adversely affect cure or local control 38. On the other hand, when dealing with advanced-stage tumors with invasion of the orbit beyond the orbital periosteum, the orbital exenteration is considered as a safe oncological procedure with better oncological rates than conservative surgery 29. In addition, recent reports have shown how orbital apex involvement appeared to be an independent prognostic factor, negatively impacting the survival rates and precluding any kind of curative treatment 3,33,42. Turri-Zanoni et al. described 24 patients with orbital apex infiltration by sinonasal cancer, reporting a 95.8% rate of recurrence and death from disease within a mean period of 21 months 3. Similarly, Nishino et al. described oncologic outcomes of multimodality treatments for patients with advanced-stage malignant tumors with orbital invasion, reporting significantly worse local control rates in patients with disease involving the orbital apex 42. In conclusion, a multidisciplinary approach is mandatory for the correct management of sinonasal cancers invading the orbit and to thoroughly define precise indications to orbital exenteration.

Reconstruction of orbital defects

The main reconstructive goal is the support and positioning of the preserved eye, since it sits adjacent to the air-filled cavities of the maxillary, ethmoid and frontal sinuses. Other objectives are aesthetic restoration of bony and soft tissue defects, and skull base reconstruction of associated dural defects, when present 43. Reconstructive options range from no reconstruction to grafts positioning, and, in selected cases, to free flap transfer, based on the extent of resection. Immediate reconstruction is recommended in order to improve healing and mitigate soft tissue contraction, especially if radiation therapy has or will be administered. Isolated papyracea defects and limited bony orbital floor defects, medial to the course of the infraorbital nerve, do not require rigid reconstruction, since the periorbit integrity itself is able to keep the position of the orbital content. Even in case of periorbital defects, the reconstruction is not routinely required since orbital stability is warranted by the intraorbital connective septal system and postoperative scar tissue is enough to restore the orbital continence 44. To promote such healing process, a U-shaped silastic sheet can be placed to keep the orbital content into the orbital cavity and prevent its prolapse into the sinonasal region 13. In selected cases, fascial grafts (temporalis or fascia lata), mucoperiosteum harvested from the middle turbinate or nasal floor/septum, or commercially available acellular dermis layer can be used to this purpose 33. Larger defects involving the orbital floor must undergo rigid reconstruction to avoid post-operative enophthalmos, globe malposition, ptosis, diplopia and ectropion 41. Titanium mesh or porous polyethylene implants can be used when post-operative irradiation is not scheduled (e.g. benign tumors) while bony free flap (e.g. scapular tip flap, iliac crest and fibular free flap) should be preferred in case of malignancies. Larger resections involving total maxillectomy, skull base removal, orbital exenteration and facial soft tissue removal require both structural and aesthetic reconstruction using distant free tissue transfer, such as chimeric anterolateral thigh flap 45, radial forearm flap or rectus abdominis flap. In addition to flap, prosthetic rehabilitation can be also helpful in these cases to restore form. Secondary procedures may be required for remodeling of the flap’s soft tissues and to provide adequate space where prosthetics can be applied.

Functional outcomes

Functional sequelae which may be observed in case of orbital preservation may include enophthalmos, diplopia, lid ectropion, epiphora, canthal dystopia, exposure keratitis and visual loss. Imola and Schramm described a grading system to assess the eye function, which stratified cases as follows: grade I, functional vision without impairment; grade II, functional vision with impairment (chronic ophthalmological sequelae); and grade III, nonfunctional eye (blindness, nonserviceable visual acuity, intractable diplopia, patched eye, or delayed exenteration) 41. In their study on 54 patients, eye function was reported as grade I in 54%, grade II in 37%, and grade III in 9%. The most common problem observed was orbit malposition due to lack of adequate rigid reconstruction of the orbital floor. However, the enophthalmos was not frequently associated with persistent diplopia, which was reported only in 9% of cases. Similarly, Turri-Zanoni et al. reported a case-series of 125 patients where the orbital preservation was achieved, obtaining functional eye without impairment in 63.2%, functional with impairment in 32.8%, and nonfunctional only in 4% 3. Both of these studies concluded that postoperative radiation increased the risk of orbital sequelae, especially for optic atrophy, cataract formation, eye dryness, and ectropion. This is supported also by Rajapurkar et al. who described two cases of decreased visual acuity and radiation-induced retinopathy from a series of 19 patients with preserved orbit 46.

Epiphora can result from stenosis of the nasolacrimal duct, lid malposition, or dry eye. Andersen et al. reported epiphora in 36% of cases 47 while Imola et Schramm found a decreased epiphora rate of 13% using a prophylactic stenting of the nasolacrimal duct 41.


Sinonasal benign and malignant tumors invading the orbit are rare and difficult to manage pathologies. An appropriate radiologic workup is paramount to assess the grade of orbital invasion and a thorough discussion with an expert radiologist can help in better defining it. To obtain complete excision of the tumor while reducing surgical morbidity and maximizing orbital preservation rates, an effective cooperation between otorhinolaryngologist, neurosurgeon, maxillofacial surgeon, and ophthalmologist is recommended, in order to select the best surgical strategy for each patient in a multidisciplinary perspective, as summarized in Table IV. In addition, based on the biology of the sinonasal tumor to treat, medical and radiation oncologists should be consulted in order to attempt multimodal therapies, including different schemes of induction chemotherapy and specific protocols of adjuvant chemoradiation. Contemporary studies show that invasion of the orbital apex is associated with reduced possibilities of complete tumor excision in both benign and malignant sinonasal tumors and adversely affects survival outcomes in case of cancers. Orbital preservation should be attempted, whenever feasible, and the reconstructive needs should be anticipated and addressed at the time of surgery so as to optimize functional and aesthetic outcomes of the preserved eye.

Figures and tables

Figure 1.Coronal (A) and axial (B) CT scan of a 32 year-old male affected by ivory osteoma with right intraorbital extension. White arrows in A and B highlight the displacement of the extrinsic ocular muscles. The patient was submitted to endoscopic endonasal resection of the lesion using the cavitation technique. The early post-operative CT scan performed 24 hours after surgery (panels C and D) ruled out any intraorbital complication. White asterisks in C and D indicate silicon roll sheets placed to maintain the orbital content within the orbital cavity and therefore prevent postoperative sequelae.

Figure 2.Contrast-enhanced MRI in coronal (A) and axial views (B) of a 46 year-old man affected by left ethmoid-maxillary inverted papilloma eroding the floor of the left orbit (black arrow in A), who underwent endoscopic endonasal resection with left medial maxillectomy type III. Postoperative MRI (C and D) excluded residual disease with hyperintense signal (black asterisk) at the left orbital floor, interpreted as post-surgical scar tissue requiring close radiological follow up. MRI performed 3 months after the surgery (E and F) demonstrated an extensive recurrence of disease involving the orbital floor (black arrowheads in E), anterior orbital content (black asterisk in F), hard palate and lateral bony wall of the left maxilla (black arrows in E), thus the patient was submitted to transfacial radical maxillectomy associated with orbital exenteration and reconstruction with an anterolateral thigh (ALT) flap. Final histology revealed an invasive SSC arising on IP. The MRI performed 3 years after the surgery (G and H) excluded local recurrences of disease (white asterisks indicate ALT flap).

Figure 3.Flowchart describing the multimodal management of sinonasal cancers with orbital invasion.

Figure 4.Contrast-enhanced MRI in coronal views (panels A and B) of a 30 year-old female affected by poorly-differentiated small cells neuroendocrine carcinoma, with intracranial involvement (black asterisk) and bilateral orbital invasion (black arrows). The patient received induction chemotherapy (cisplatin/etoposide scheme, 5 cycles) with complete response. The patient was therefore submitted to exclusive chemoradiation with curative intent. The contrast-enhanced MRI performed 2 years after treatment excluded recurrences of disease (C and D).

Figure 5.Contrast-enhanced MRI in coronal views (A and B) of a 69 year-old man affected by locally advanced sinonasal undifferentiated carcinoma involving the left orbit (white arrows). The patient underwent induction chemotherapy (TPF scheme, 5 cycles) obtaining partial response (black asterisks in panels C and D indicate the persistence of disease). A left unilateral endoscopic resection with transnasal craniectomy and skull base reconstruction (white arrowheads) was performed to remove the residual disease. Finally, the patient received adjuvant irradiation using intensity-modulated radiotherapy (62 Gy). The contrast-enhanced MRI performed 5 years after treatment showed no evidence of disease (E and F).

Figure 6.Contrast-enhanced MRI in coronal (A, T1 contrast-weighted and B, T2-weighted sequences) and axial (C, T1 contrast-weighted) views of a 51 year-old man affected by locally advanced well-differentiated squamous cell carcinoma involving the left orbit (white arrows indicate medial and inferior rectus muscles infiltration) and encroaching the anterior skull base. The patient underwent a bilateral endoscopic endonasal resection associated with skull base reconstruction and left orbital exenteration, followed by adjuvant irradiation (66 Gy). The contrast-enhanced MRI performed 3 years after treatment excluded recurrences of disease (panels D, E and F).

Author, year N. of cases Histology Endoscopic or external surgical approach & other treatments Mean follow-up (months) Recurrences & persistences/treated cases Orbital preservation rate
Wang, 2014 9 14 Ossifying fibroma 10, EEA (71%)4, TTA (29%) 25 6/14 (43%) 14/14 (100%)
Ye, 2017 11 12 Ossifying fibroma 12, EEA (100%) 43.1 2/12 (17%) 12/12 (100%)
Turri-Zanoni, 2012 12 6 Osteoma 4, EEA (66%)1, EEA+TTA (17%)1, TTA (17%) 72.6 - 6/6 (100%)
Bertin, 2020 48 12 Fibrous dysplasia 6, TTA (50%)3, Bifosfonate (25%)3, Wait&scan (25%) 20.8 12/12 (100%) 12/12 (100%)
Ricalde, 2001 10 6 Fibrous dysplasia 6, TTA (100%) NA NA 6/6 (100%)
Elmer, 1995 15 10 Inverted papilloma 2, TTA (20%)8, Orbital exenteration 51.6 8/10 (80%) 2/10 (20%)
Saldana, 2013 18 6 Inverted papilloma 6, TTA (100%)+(3, RT) 22.8 - 5/6 (84%)
Xu, 2012 23 18 Juvenile angiofibroma 10, EEA + TTA8, TTA+(4, RT) NA 6/18 (34%) 18/18 (100%)
Table I.Literature review of the main case-series describing treatment outcomes of sinonasal benign tumors with orbital involvement.
Author, year of publication Grading of orbital invasion Treatment
McCary et al., 1996 35 A Tumor adjacent the orbit without infiltration of the orbital wall RT/CT + surgery
B Tumor eroding the orbital wall without ocular bulb displacement
C Tumor eroding, infiltrating and displacing the orbital wall without periorbital invasion
D Tumor invading the orbit with periorbital invasion RT/CT + surgery with resection of involved periorbita (exenteration if extensive involvement)
Iannetti et al., 2005 36 1 Erosion or destruction of medial orbital wall Resection of medial orbital wall
2 Extraconal invasion of periorbital fat
3 Invasion of medial rectal muscle, optic nerve, ocular bulb or skin overlying the eyelid Orbital exenteration
Neel et al., 2016 32 1 Tumor adjacent to orbital wall, which may be thinned, bowed or eroded without periorbital invasion Drilling and resection of involved bone
2 Tumor eroding the orbital wall, with resectable periorbital involvement Resection of periorbita and underlying extraconal orbital fat
3 Tumor with extraocular muscle, intraconal fat, globe or orbital apex invasion Orbital clearance
4 Tumor invading the nasolacrimal system, eyelids duct and/or sac Orbital exenteration
5 Tumor with cavernous sinus, optic canal or massive intracranial invasion Unresectable, pallation
Turri-Zanoni et al., 2018 3 1 Erosion or destruction of lamina papyracea Endoscopic endonasal surgery
2 Invasion of the periorbital layer and/or focal invasion of the extraconic periorbital fat
3 Invasion of the anterior 2/3 of the orbit Orbital exenteration
4 Involvement of the orbital apex Unresectable, palliation
Table II.Grading systems of orbital invasion and relative treatments.
Authors N. of cases Degree of orbital invasion Treatment strategies Oncological outcomes Conclusions
Carrau 1999 4 58 36% orbital invasion (bone and soft tissues) Surgical resection + adjuvant treatment NED 56% cases after orbital preservationNED 50% cases after orbital exenteration Orbital sparing is possible when soft tissues are uninvolved, without affecting oncological outcomes
Imola and Schramm 2002 40 66 54 pt with bony wall or periorbital involvement12 pt with intraorbital involvement SurgerypoRT in 44 cases LRR 29.6% after orbital preservationLRR 33.3% after orbital exenteration Selective orbital preservation does not seem to adversely affect survival or local control
Iannetti 2005 36 29 24.1% medial orbital wall invasion20.7% extraconal fat invasion37.9% intraconal or eyelid skin invasion CFSpoRT 37.9% 5y OS 71.4% with medial orbital wall invasion5y OS 33.3% with extraconal fat invasion5y OS 50.9% with intraconal fat invasion Orbital exenteration is necessary in case of intraconal fat invasion
Ganly 2005 49 334 33.8% bone16.5% periosteum15% orbital contents CFSpoRT 48% 5y DSS 75% with no orbital invasion5y DSS 40.7% with bone/periosteum invasion5y DSS 44.4% with intraorbital invasion Orbital contents invasion was a negative PF in univariate analysis, but not statistically significant in multivariate analysis
Patel 2003 38 1306 24.6% bone10.5% periosteum22.5% orbital content CFSpoRT 39% 5y DSS 66.2% with no orbital invasion5y DSS 59.2% with bone/periosteal invasion5y DSS 48.2% with orbital contents invasion Orbital contents invasion is a negative PF in univariate analysis, but not statistically significant in multivariate analysis
Howard 2006 39 308 No orbital involvement in 56% of pt CFSAdjuvant treatment 40% (mainly RT) 5y OS 52% with no orbital involvement5y OS 45% with periosteal invasion5y OS 14% with orbital involvement Orbital spread is a negative PF
Suarez 2004 37 100 36% periosteum14% deep orbital involvement CFSAdjuvant treatment 55% (mainly RT) 5y OS 44% with no deep orbital invasion5y OS 16% with deep orbital invasion Deep orbital involvement is a negative PF
Safi 2017 28 52 100% invading the orbit beyond orbital periosteum CFSSurgery + poRT 5y OS 14% after orbital preservation + poRT5y OS 65.5% after orbital exenteration In case of orbital content invasion, exenteration shows better survival rate than conservative surgery
Turri-Zanoni 2018 3 196 Grade 1: 44 ptGrade 2: 46 ptGrade 3: 49 ptGrade 4: 24 pt 27 pt orb. exenteration112 pt orb. preservation5 cases treated with CTRTGrade 4 patients:11 pt orb. exenteration13 pt orb. preservation 5y OS 84% for grade 15y OS 64.1% for grade 25y OS 48.9% for grade 35y OS 14.6% for grade 4 Orbital invasion represents a negative prognostic factor.Neoadjuvant chemotherapy can downstage the local extension of the tumor and maximize orbital preservation ratesCancers invading the orbital apex must be considered incurable
Table III.Literature review.
Pathology Rate of orbital invasion (%) Multidisciplinary management Orbital preservation
IP 2-4% Recommended Almost invariably
FOLs 12-15% Recommended Almost invariably
JNA 27-32% Recommended Almost invariably
Low grade cancer (adenocarcinoma, ACC, low grade ONB, SCC); chemoresistant tumor (MM) 35-45% Mandatory Highly selected cases (according to the grade of orbital invasion)
High grade cancer (SNUC, SCC-G3, NEC, ONB grade IV, p53wt ITAC) 50-80% Mandatory Selected case (according to the response to induction chemotherapy)
Table IV.Summary of evidences available in literature concerning the multidisciplinarymanagement of sinonasal benign and malignant tumours with orbital invasion.


  1. Ketcham AS, Wilkins RH, Vanburen JM. A combined intracranial facial approach to the paranasal sinuses. Am J Surg. 1963; 106:698-703. DOI
  2. Lisan Q, Kolb F, Temam S, Tao Y. Management of orbital invasion in sinonasal malignancies. Head Neck. 2016; 38:1650-1606. DOI
  3. Turri-Zanoni M, Lambertoni A, Margherini S. Multidisciplinary treatment algorithm for the management of sinonasal cancers with orbital invasion: A retrospective study. Head Neck. 2019; 41:2777-2788. DOI
  4. Carrau RL, Segas J, Nuss DW. Squamous cell carcinoma of the sinonasal tract invading the orbit. Laryngoscope. 1999; 109:230-235. DOI
  5. Farina D, Borghesi A, Botturi E. Treatment monitoring of paranasal sinus tumors by magnetic resonance imaging. Cancer Imaging. 2010; 10:183-193. DOI
  6. Jørgensen M, Heegaard S. A review of nasal, paranasal, and skull base tumors invading the orbit. Surv Ophthalmol. 2018; 63:389-405. DOI
  7. Duan C, Dai Q, Liu Q. Characteristics of sinonasal fibrous dysplasia: experience from a single department. Acta Otolaryngol. 2018; 138:50-55. DOI
  8. Georgalas C, Goudakos J, Fokkens WJ. Osteoma of the skull base and sinuses. Otolaryngol Clin North Am. 2011; 44:875-890, vii. DOI
  9. Wang H, Sun X, Liu Q. Endoscopic resection of sinonasal ossifying fibroma: 31 cases report at an institution. Eur Arch Otorhinolaryngol. 2014; 271:2975-2982. DOI
  10. Ricalde P, Magliocca KR, Lee JS. Craniofacial fibrous dysplasia. Oral Maxillofac Surg Clin North Am. 2012; 24:427-441. DOI
  11. Ye P, Huang Q, Zhou B. Endoscopic resection of ossifying fibroma involving paranasal sinuses and the skull base in a series of 15 cases. Acta Otolaryngol. 2017; 137:786-790. DOI
  12. Turri-Zanoni M, Dallan I, Terranova P. Frontoethmoidal and intraorbital osteomas: exploring the limits of the endoscopic approach. Arch Otolaryngol Head Neck Sur. 2012; 138:498-504. DOI
  13. Karligkiotis A, Appiani MC, Verillaud B. How to prevent diplopia in endoscopic transnasal resection of tumors involving the medial orbital wall. Laryngoscope. 2014; 124:2017-2020. DOI
  14. Leong LT, Ming BJ. Craniofacial fibrous dysplasia involving the orbit: a case report and literature review. Asia Pac J Ophthalmol (Phila). 2015; 4:151-154. DOI
  15. Elner VM, Burnstine MA, Goodman ML. Inverted papillomas that invade the orbit. Arch Ophthalmol. 1995; 113:1178-1183. DOI
  16. Wang J, Ford J, Esmaeli B. Inverted papilloma of the orbit and nasolacrimal system. Ophthalmic Plast Reconstr Surg. 2021; 37:161-167. DOI
  17. Johnson LN, Krohel GB, Yeon EB. Sinus tumors invading the orbit. Ophthalmology. 1984; 91:209-217. DOI
  18. Saldana M, Wearne M, Beigi B. Inverted papillomas of the nasal and paranasal sinuses that involve the ocular/adnexal region. Orbit. 2013; 32:366-369. DOI
  19. Chaudhry IA, Taiba K, Al-Sadhan Y. Inverted papilloma invading the orbit through the nasolacrimal duct: a case report. Orbit. 2005; 24:135-139. DOI
  20. Bajaj MS, Pushker N. Inverted papilloma invading the orbit. Orbit. 2002; 21:155-159. DOI
  21. Mendenhall WM, Hinerman RW, Malyapa RS. Inverted papilloma of the nasal cavity and paranasal sinuses. Am J Clin Oncol. 2007; 30:560-563. DOI
  22. Cruz AA, Atique JM, Melo-Filho FV. Orbital involvement in juvenile nasopharyngeal angiofibroma: prevalence and treatment. Ophthalmic Plast Reconstr Surg. 2004; 20:296-300. DOI
  23. Xu Y, Lin G, Lin C. Treatment and prognosis of nasopharyngeal angiofibroma involving the eye and optic nerve. J Laryngol Otol. 2012; 126:1108-1113. DOI
  24. Trivedi M, Desai RJ, Potdar NA. Vision loss due to central retinal artery occlusion following embolization in a case of a giant juvenile nasopharyngeal angiofibroma. J Craniofac Surg. 2015; 26:e451-453. DOI
  25. López F, Triantafyllou A, Snyderman CH. Nasal juvenile angiofibroma: Current perspectives with emphasis on management. Head Neck. 2017; 39:1033-1045. DOI
  26. Langdon C, Herman P, Verillaud B. Expanded endoscopic endonasal surgery for advanced stage juvenile angiofibromas: a retrospective multi-center study. Rhinology. 2016; 54:239-246. DOI
  27. Reyes C, Bentley H, Gelves JA. Recurrence rate after endoscopic vs. open approaches for juvenile nasopharyngeal angiofibroma: a meta-analysis. J Neurol Surg B Skull Base. 2019; 80:577-585. DOI
  28. Castelnuovo P, Battaglia P, Bignami M. Endoscopic transnasal resection of anterior skull base malignancy with a novel 3D endoscope and neuronavigation. Acta Otorhinolaryngol Ital. 2012; 32:189-191.
  29. Safi AF, Behn L, Rothamel D. Therapy of sinonasal malignancies invading the orbit-orbital exenteration versus preservation of the orbit plus radiotherapy. J Craniomaxillofac Surg. 2017; 45:258-261. DOI
  30. Vartanian JG, Toledo RN, Bueno T. Orbital exenteration for sinonasal malignancies: indications, rehabilitation and oncologic outcomes. Curr Opin Otolaryngol Head Neck Surg. 2018; 26:122-126. DOI
  31. Castelnuovo P, Turri-Zanoni M, Battaglia P. Sinonasal malignancies of anterior skull base: histology-driven treatment strategies. Otolaryngol Clin North Am. 2016; 49:183-200. DOI
  32. Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck. 2012; 34:877-885. DOI
  33. Neel GS, Nagel TH, Hoxworth JM. Management of orbital involvement in sinonasal and ventral skull base malignancies. Otolaryngol Clin North Am. 2017; 50:347-364. DOI
  34. Muscatello L, Fortunato S, Seccia V. The implications of orbital invasion in sinonasal tract malignancies. Orbit. 2016; 35:278-284. DOI
  35. Maroldi R, Farina D, Battaglia G. MR of malignant nasosinusal neoplasms. Frequently asked questions. Eur J Radiol. 1997; 24:181-190. DOI
  36. McCary WS, Levine PA, Cantrell RW. Preservation of the eye in the treatment of sinonasal malignant neoplasms with orbital involvement. A confirmation of the original treatise. Arch Otolaryngol Head Neck Surg. 1996; 122:657-659. DOI
  37. Iannetti G, Valentini V, Rinna C. Ethmoido-orbital tumors: our experience. J Craniofac Surg. 2005; 16:1085-1091. DOI
  38. Suárez C, Ferlito A, Lund VJ. Management of the orbit in malignant sinonasal tumors. Head Neck. 2008; 30:242-250. DOI
  39. Patel SG, Singh B, Polluri A. Craniofacial surgery for malignant skull base tumors: report of an international collaborative study. Cancer. 2003; 98:1179-1187. DOI
  40. Howard DJ, Lund VJ, Wei WI. Craniofacial resection for tumors of the nasal cavity and paranasal sinuses: a 25-year experience. Head Neck. 2006; 28:867-873. DOI
  41. Imola MJ, Schramm VL. Orbital preservation in surgical management of sinonasal malignancy. Laryngoscope. 2002; 112:1357-1365. DOI
  42. Nishino H, Ichimura K, Tanaka H. Results of orbital preservation for advanced malignant maxillary sinus tumors. Laryngoscope. 2003; 113:1064-1069. DOI
  43. Battaglia P, Turri-Zanoni M, De Bernardi F. Septal flip flap for anterior skull base reconstruction after endoscopic resection of sinonasal cancers: preliminary outcomes. Acta Otorhinolaryngol Ital. 2016; 36:194-198. DOI
  44. Castelnuovo P, Turri-Zanoni M, Battaglia P. Endoscopic endonasal management of orbital pathologies. Neurosurg Clin N Am. 2015; 26:463-472. DOI
  45. Cherubino M, Turri-Zanoni M, Battaglia P. Chimeric anterolateral thigh free flap for reconstruction of complex cranio-orbito-facial defects after skull base cancers resection. J Craniomaxillofac Surg. 2017; 45:87-92. DOI
  46. Rajapurkar M, Thankappan K, Sampathirao LM. Oncologic and functional outcome of the preserved eye in malignant sinonasal tumors. Head Neck. 2013; 35:1379-1384. DOI
  47. Andersen PE, Kraus DH, Arbit E. Management of the orbit during anterior fossa craniofacial resection. Arch Otolaryngol Head Neck Sur. 1996; 122:1305-1307. DOI
  48. Bertin H, Huon JF, Guillot P. Fibrous dysplasia of the orbital region: series of 12 cases and review of the literature. J Fr Ophtalmol. 2020; 43:467-476. DOI
  49. Ganly I, Patel SG, Singh B. Craniofacial resection for malignant paranasal sinus tumors: report of an International Collaborative Study. Head Neck. 2005; 27:575-584. DOI


Paolo Castelnuovo

Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy; Head and Neck Surgery & Forensic Dissection Research center (HNS&FDRc), Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy

Alessia Lambertoni

Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy

Giorgio Sileo

Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy

Marco Valentini

Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy

Apostolos Karligkiotis

Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy

Paolo Battaglia

Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy; Head and Neck Surgery & Forensic Dissection Research center (HNS&FDRc), Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy

Mario Turri-Zanoni

Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy; Head and Neck Surgery & Forensic Dissection Research center (HNS&FDRc), Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy


© Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale , 2021

  • Abstract viewed - 323 times
  • PDF downloaded - 188 times